Literature DB >> 9841984

Role of cyclooxygenase-2 for fluid secretion by the inflamed gallbladder mucosa.

B Nilsson1, D Delbro, L Hedin, S Friman, S Andius, J Svanvik.   

Abstract

Inflammatory fluid secretion by the gallbladder mucosa in experimental cholecystitis is induced by activation of cyclooxygenase, which leads to an increase in prostaglandin formation. Cyclooxygenase exists as a constitutive (cyclooxygenase-l) and an inducible (cyclooxygenase-2) isoform. The aim of this study was to demonstrate the role of cyclooxygenase-2 in inflammatory fluid secretion of the feline gallbladder. Experiments were performed 10 weeks after a surgical procedure in which chronic cholecystitis was induced in cats by ligation of the cystic duct and implantation of a gallstone in the gallbladder. Gallbladder fluid transport was continuously monitored via a perfusion system. In inflammed gallbladders the continuous fluid secretion was reversed to absorption by intravenous injection of the selective cyclooxygenase-2 blocker, NS 398 (P <0.001). Increased levels of the inducible cyclooxygenase-2 were shown by immunoblotting in inflamed gallbladders. Selective pharmacologic blockage of cyclooxygenase-2 reduced the prostaglandin E2 release to the inflamed gallbladder lumen (P <0.01). These data suggest that cyclooxygenase-2 is involved in the inflammatory response during chronic cholecystitis. Selective cyclooxygenase-2 blockers may offer an alternative to traditional nonsterodial anti-inflammatory drugs with fewer side effects in patients with cholecystitis who are awaiting operation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841984     DOI: 10.1016/s1091-255x(98)80022-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  28 in total

1.  Intraluminal prostaglandin E2 affects gallbladder function by activation of intramural nerves in the anaesthetized cat.

Authors:  L Jivegård; A Thune; J Svanvik
Journal:  Acta Physiol Scand       Date:  1988-04

2.  Vasoactive intestinal peptide in the normal and inflamed feline gallbladder.

Authors:  L Jivegård; J Fahrenkrug; J Svanvik
Journal:  Regul Pept       Date:  1989-05

3.  VIP-antiserum inhibits fluid secretion by the inflamed gallbladder mucosa.

Authors:  B Nilsson; E Theodorsson; L Jivegård; A Thune; S Friman; J Svanvik
Journal:  Regul Pept       Date:  1994-01-13

4.  Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig.

Authors:  C Dupont; J P Broyart; Y Broer; B Chenut; M Laburthe; G Rosselin
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

5.  NADPH-diaphorase activity in neurons of the mammalian pancreas: coexpression with vasoactive intestinal polypeptide.

Authors:  T Shimosegawa; T Abe; A Satoh; R Abe; Y Kikuchi; M Koizumi; T Toyota
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

6.  Distribution of certain peptide-containing nerve fibres and endocrine cells in the gastrointestinal mucosa in five mammalian species.

Authors:  J R Keast; J B Furness; M Costa
Journal:  J Comp Neurol       Date:  1985-06-15       Impact factor: 3.215

7.  Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Authors:  J A Mitchell; P Akarasereenont; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Role of nitric oxide in induction of inflammatory fluid secretion by the mucosa of the feline gallbladder.

Authors:  B Nilsson; D Delbro; L Hedin; N Conradi; A Thune; S Friman; A Wennmalm; Z Q Yan; J Svanvik
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

Review 9.  Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.

Authors:  G Engelhardt
Journal:  Br J Rheumatol       Date:  1996-04

10.  Gallbladder function in experimental cholecystitis.

Authors:  J Svanvik; E Thornell; L Zettergren
Journal:  Surgery       Date:  1981-04       Impact factor: 3.982

View more
  2 in total

1.  Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion.

Authors:  R V Rege
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

Review 2.  Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer.

Authors:  Pablo Pérez-Moreno; Ismael Riquelme; Patricia García; Priscilla Brebi; Juan Carlos Roa
Journal:  J Pers Med       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.